Subscribe
Magazine
Past Issues
Surveys
Industry Statistics
About Us
Members Only
Best Places to Work
General Interest
Exploration & Development
Drilling & Production
Refining & Processing
Pipelines & Transportation
LNG
Energy Transition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
PennEnergy Stock Watch
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Vistagen Therapeutics Inc
(NQ:
VTGN
)
3.600
+0.010 (+0.28%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Vistagen Therapeutics Inc
< Previous
1
2
3
4
5
6
Next >
VTGN Stock Earnings: VistaGen Therapeutics Beats EPS, Misses Revenue for Q1 2025
August 13, 2024
VTGN stock results show that VistaGen Therapeutics beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2025.
Via
InvestorPlace
3 Stocks Under $15 That Could Make You a Millionaire
July 26, 2024
Investors looking for millionaire status in the coming years should consider three stocks under $15 that could be worth buying.
Via
InvestorPlace
VTGN Stock Earnings: VistaGen Therapeutics Beats EPS, Misses Revenue for Q4 2024
June 12, 2024
VTGN stock results show that VistaGen Therapeutics beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2024.
Via
InvestorPlace
3 Must-Have Penny Stocks to Boost Your 2024 Portfolio
May 14, 2024
Though volatility remains high, these penny stocks promise significant returns, especially in this high-interest rate economic climate.
Via
InvestorPlace
Meme Stock Rebound: 3 Reddit Favorites Primed for a Resurgence
May 13, 2024
The internet and forums such as Reddit, are rife with misinformation about stock prospects. However, these three might have potential.
Via
InvestorPlace
7 Stocks Under $15 Predicted to Boom in the Next 2 Years
April 19, 2024
Discover seven promising stocks priced under $15, leading in sectors like financial services, biotechnology, and energy.
Via
InvestorPlace
Recap: Vistagen Therapeutics Q3 Earnings
February 13, 2024
Via
Benzinga
VistaGen Therapeutics's Earnings: A Preview
February 12, 2024
Via
Benzinga
VistaGen Therapeutics Earnings Preview
November 08, 2023
Via
Benzinga
Millionaire Makers: 3 Stocks Under $10 Set to Skyrocket by 2027
April 09, 2024
Explore three stocks under $10 in electronic equipment and instruments, technology hardware, storage and peripherals, and biotechnology.
Via
InvestorPlace
Secret Superstars: 3 Unknown Stocks to Turn $5K into $100K by 2027
March 31, 2024
Learn the potency of lesser-known stocks and explore their fundamental edge in technology distribution, food retail, and biotechnology.
Via
InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
February 19, 2024
Via
Benzinga
3 Revolutionary Biotech Stocks Poised for 10X Surge
February 19, 2024
Discover three biotech stocks set to soar in a $3.08 trillion market, merging medical innovations with financial growth opportunities.
Via
InvestorPlace
3 Hidden-Gem Biotech Stocks Ready to Ride a Massive Market Wave
February 14, 2024
Explore hidden-gem biotech stocks set for growth in a booming market. Uncover top picks ready to redefine healthcare innovation.
Via
InvestorPlace
Earnings Scheduled For February 13, 2024
February 13, 2024
Companies Reporting Before The Bell • LCI Indus (NYSE:LCII) is likely to report quarterly earnings at $0.18 per share on revenue of $838.27 million.
Via
Benzinga
3 Penny Stocks to Buy for the Next Bull Run: February 2024
February 07, 2024
As the market pivots in 2024, dive into the dynamic world of penny stocks, revealing the top choices for February's exhilarating bull run.
Via
InvestorPlace
3 Penny Stocks to Turn $999 Into $1 Million: January 2024
January 26, 2024
With our strengthening economy, you need to invest in penny stocks that will deliver high future returns, these three are your best bets.
Via
InvestorPlace
Topics
Economy
Exposures
Economy
Undervalued VistaGen Therapeutics, Analyst Highlights Potential In Anxiety Treatment
December 04, 2023
William Blair initiated coverage on VistaGen Therapeutics Inc (NASDAQ: VTGN), a clinical-stage biopharmaceutical company focused on developing next-generation treatment options for social anxiety...
Via
Benzinga
Anxiety-Focused Stock Vistagen Therapeutics Is An Undervalued Late-Stage Neurology Player: Analyst
November 14, 2023
Analysts at Stifel recently initiated coverage on Vistagen Therapeutics Inc (NASDAQ: VTGN), emphasizing the potential of its lead asset, fasedienol, in clinical development for social anxiety disorder...
Via
Benzinga
Why Vistagen Therapeutics Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
October 17, 2023
Gainers SciSparc Ltd. (NASDAQ: SPRC) shares surged 79.5% to $5.08 in pre-market trading after falling around 7% on Monday. SciSparc recently regained compliance with the Nasdaq Minimum Bid Price...
Via
Benzinga
Earnings Scheduled For November 9, 2023
November 09, 2023
Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnings at $0.30 per share on revenue of $265.00 million.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
October 17, 2023
It's time for another dive into the biggest pre-market stock movers as we list out the top stocks worth watching on Tuesday!
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
October 05, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
October 02, 2023
Via
Benzinga
Why Intelligent Bio Solutions Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day Session
October 02, 2023
Gainers AERWINS Technologies Inc. (NASDAQ: AWIN) shares climbed 86.1% to $0.2248 after the company said it is considering strategic alternatives for its non-core operations.
Via
Benzinga
The 7 Best Short-Squeeze Stocks to Buy Now: September 2023
September 21, 2023
Explore the potential of the best short-squeeze stocks to buy now as companies attempt to prove pessimistic traders wrong.
Via
InvestorPlace
10 Short Squeeze Stocks To Watch: Getty Images, Bitcoin Depot, Blue Apron Holdings And More
September 11, 2023
Potential short squeeze plays gained steam in 2021, continued throughout 2022, and remain a focus of traders looking for the next huge move. High short interest and steep borrowing costs are among the...
Via
Benzinga
10 Short Squeeze Stocks To Watch: Blue Apron, Getty Images, Black Rifle Coffee And More
September 05, 2023
Potential short squeeze plays gained steam in 2021, continued throughout 2022, and remain a new focus of traders looking for the next huge move. High short interest and steep borrowing costs are among...
Via
Benzinga
10 Short Squeeze Stocks To Watch: Getty Images, Blue Apron, T Stamp, Black Rifle Coffee And More
August 28, 2023
Potential short squeeze plays gained steam in 2021, continued throughout 2022, and remain a new focus of traders looking for the next huge move. High short interest and steep borrowing costs are among...
Via
Benzinga
Why Krispy Kreme Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
August 10, 2023
Gainers Edible Garden AG Incorporated (NASDAQ: EDBL) shares jumped 58% to $1.88 after the company reported better-than-expected second-quarter financial results.
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.